Suchergebnisse - "Zenz, Thorsten"

PubPharm (334)

51

The protein landscape of chronic lymphocytic leukemia

enthalten in: Blood | 2021

von Meier-Abt, F. | Lu, J. | Cannizzaro, E. | +17

CommentIn: Blood. 2021 Dec 16;138(24):2448-2450. - PMID 34914830

52

The balance between the intronic miR-342 and its host gene Evl determines hematopoietic cell fate decision

enthalten in: Leukemia | 2021

von Herbst, F. | Lang, T. | Eckert, E. | +15

53

CXCR4 hyperactivation cooperates with TCL1 in CLL development and aggressiveness

enthalten in: Leukemia | 2021

von Lewis, R. | Maurer, H. | Singh, N. | +16

54

Multi-omics reveals clinically relevant proliferative drive associated with mTOR-MYC-OXPHOS activity in chronic lymphocytic leukemia

enthalten in: Nature cancer | 2021

von Lu, J. | Cannizzaro, E. | Meier-Abt, F. | +20

55

SAMHD1 mutations in mantle cell lymphoma are recurrent and confer in vitro resistance to nucleoside analogues

enthalten in: Leukemia research | 2021

von Bühler, M. | Lu, J. | Scheinost, S. | +14

56

Hairy cell leukemia and COVID-19 adaptation of treatment guidelines

enthalten in: Leukemia | 2021

von Grever, M. | Andritsos, L. | Banerji, V. | +36

57

Targeted PI3K/AKT-hyperactivation induces cell death in chronic lymphocytic leukemia

enthalten in: Nature communications | 2021

von Ecker, V. | Stumpf, M. | Brandmeier, L. | +15

58

IGLV3-21R110 identifies an aggressive biological subtype of chronic lymphocytic leukemia with intermediate epigenetics

enthalten in: Blood | 2021

von Nadeu, F. | Royo, R. | Clot, G. | +11

CommentIn: Blood. 2021 May 27;137(21):2863-2865. - PMID 34042978

59

Control of PD-L1 expression in CLL-cells by stromal triggering of the Notch-c-Myc-EZH2 oncogenic signaling axis

enthalten in: Journal for immunotherapy of cancer | 2021

von Böttcher, M. | Bruns, H. | Völkl, S. | +12

60

Subgroup-specific gene expression profiles and mixed epistasis in chronic lymphocytic leukemia

enthalten in: bioRxiv.org | 2021

von Lütge, A. | Lu, J. | Hüllein, J. | +8